Castle Biosciences, Inc.

Castle Biosciences Beats on EPS, Stock Up 3.72%

Castle Biosciences reported a narrower-than-expected loss per share, which contributed to a positive stock reaction, with shares rising by 3.72%. However, the lack of revenue figures and management guidance leaves some uncertainty about the company's future performance. Investors will need to watch for further updates as more information becomes available.